Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Onaitis Matthew Create: Alert

All | News | Filings
Date FiledTypeDescription
04/02/2018 4 Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 72,000 options to buy @ $4, valued at $288k
09/19/2017 4 Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
Exercised 25,000 restricted stock units @ $0
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/05/2016 4 Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 110,000 options to buy @ $10.45, valued at $1.1M
01/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/09/2015 4 Onaitis Matthew (General Counsel and Secretary) has filed a Form 4 on Ignyta, Inc.
Txns: Granted 20,000 shares @ $0
Granted 44,160 options to buy @ $6.58, valued at $290.6k
09/13/2013 4 Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 100,000 options to buy @ $7.67, valued at $767k
06/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/08/2013 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Pernix Sleep, Inc.
Txns: Disposed/sold 47,098 shares @ $0
11/20/2012 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Granted 30,000 shares @ $0
10/02/2012 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Granted 15,716 shares @ $0
07/03/2012 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Granted 15,992 shares @ $0
01/04/2012 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Sold 9,000 shares @ $0.4767, valued at $4.3k
12/03/2010 4 Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Sold 8,468 shares @ $2.6835, valued at $22.7k
04/05/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
03/22/2010 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 5,580 shares @ $3.94, valued at $22k
Sold 2,627 shares @ $7, valued at $18.4k
Sold 15,000 shares @ $6.5921, valued at $98.9k
Sold 14,454 shares @ $9, valued at $130.1k
Exercised 4,166 options to buy @ $1.23, valued at $5.1k
Exercised 17,945 options to buy @ $1.23, valued at $22.1k
Exercised 2,066 options to buy @ $1.23, valued at $2.5k
Exercised 1,111 options to buy @ $1.23, valued at $1.4k
03/03/2010 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Sold 30,000 shares @ $4.0155, valued at $120.5k
Exercised 9,066 options to buy @ $1.23, valued at $11.2k
Exercised 20,934 options to buy @ $1.23, valued at $25.7k
02/09/2010 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Sold 60,000 shares @ $3.0251, valued at $181.5k
Exercised 25,000 options to buy @ $1.23, valued at $30.8k
Exercised 12,400 options to buy @ $1.23, valued at $15.3k
Exercised 6,666 options to buy @ $1.23, valued at $8.2k
Exercised 15,934 options to buy @ $1.23, valued at $19.6k
01/05/2010 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
Txns: Sold 5,000 shares @ $1.07, valued at $5.4k
07/20/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities
06/10/2009 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
02/19/2009 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.
12/02/2008 4 Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy